| Dr Lynn E Bezpalko, DO | |
|
77 Nautilus Dr, Manahawkin, NJ 08050-2448 | |
| (609) 597-0321 | |
| (609) 597-0014 |
| Full Name | Dr Lynn E Bezpalko |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 32 Years |
| Location | 77 Nautilus Dr, Manahawkin, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356417570 | NPI | - | NPPES |
| DO7250800 | Other | NJ | CDS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 25MB06604900 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southern Ocean Medical Center | Manahawkin, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern Ocean Otolaryngology,pa | 4981659281 | 2 |
News Archive
A study of patient electronic medical records and genome sequences from adults with age-related hearing impairment by researchers at UC San Francisco and Kaiser Permanente Northern California, identified two genetic variations linked to the hearing disorder.
Agilent Technologies Inc. today announced a favorable decision in its trade secrets and breach of contract case against Advanced Materials Technology, Inc. (AMT) and three of its employees in the Delaware Court of Chancery. Agilent filed the lawsuit in January 2008 to protect confidential and proprietary information relating to its high-performance liquid chromatography technology.
Atrix Laboratories, Inc. has announced today that the company has signed a limited feasibility agreement with Aventis SA (NYSE: AVE) to begin preliminary research on two proprietary Aventis compounds formulated in Atrix's delivery technology, Atrigel®. The current agreement is specific for these compounds in an undisclosed therapeutic area.
Human movement is a key factor of dengue virus inflow in Rio de Janeiro, according to results from researchers based at the Oswaldo Cruz Foundation (Fiocruz) in Brazil. The results, based on data from a severe epidemic in 2007-2008, contribute to new understanding on the dynamics of dengue fever in the second largest city in Brazil. Details are published November 10 in the open-access journal PLoS Neglected Tropical Diseases.
DK Sinopharma, Inc., formerly known as Virtual Closet, Inc. today announced that on June 30, 2010, the Company's name change from Virtual Closet, Inc. to DK Sinopharma, Inc. took effect in the marketplace. The OTCBB symbol has also changed from VIRZ to DKSP to reflect the change in name. The name and symbol change became effective through FINRA on June 30, 2010.
› Verified 6 days ago
| Entity Name | Southern Ocean Otolaryngology,pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285701862 PECOS PAC ID: 4981659281 Enrollment ID: O20050321000224 |
News Archive
A study of patient electronic medical records and genome sequences from adults with age-related hearing impairment by researchers at UC San Francisco and Kaiser Permanente Northern California, identified two genetic variations linked to the hearing disorder.
Agilent Technologies Inc. today announced a favorable decision in its trade secrets and breach of contract case against Advanced Materials Technology, Inc. (AMT) and three of its employees in the Delaware Court of Chancery. Agilent filed the lawsuit in January 2008 to protect confidential and proprietary information relating to its high-performance liquid chromatography technology.
Atrix Laboratories, Inc. has announced today that the company has signed a limited feasibility agreement with Aventis SA (NYSE: AVE) to begin preliminary research on two proprietary Aventis compounds formulated in Atrix's delivery technology, Atrigel®. The current agreement is specific for these compounds in an undisclosed therapeutic area.
Human movement is a key factor of dengue virus inflow in Rio de Janeiro, according to results from researchers based at the Oswaldo Cruz Foundation (Fiocruz) in Brazil. The results, based on data from a severe epidemic in 2007-2008, contribute to new understanding on the dynamics of dengue fever in the second largest city in Brazil. Details are published November 10 in the open-access journal PLoS Neglected Tropical Diseases.
DK Sinopharma, Inc., formerly known as Virtual Closet, Inc. today announced that on June 30, 2010, the Company's name change from Virtual Closet, Inc. to DK Sinopharma, Inc. took effect in the marketplace. The OTCBB symbol has also changed from VIRZ to DKSP to reflect the change in name. The name and symbol change became effective through FINRA on June 30, 2010.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lynn E Bezpalko, DO 77 Nautilus Dr, Manahawkin, NJ 08050-2448 Ph: (609) 597-0321 | Dr Lynn E Bezpalko, DO 77 Nautilus Dr, Manahawkin, NJ 08050-2448 Ph: (609) 597-0321 |
News Archive
A study of patient electronic medical records and genome sequences from adults with age-related hearing impairment by researchers at UC San Francisco and Kaiser Permanente Northern California, identified two genetic variations linked to the hearing disorder.
Agilent Technologies Inc. today announced a favorable decision in its trade secrets and breach of contract case against Advanced Materials Technology, Inc. (AMT) and three of its employees in the Delaware Court of Chancery. Agilent filed the lawsuit in January 2008 to protect confidential and proprietary information relating to its high-performance liquid chromatography technology.
Atrix Laboratories, Inc. has announced today that the company has signed a limited feasibility agreement with Aventis SA (NYSE: AVE) to begin preliminary research on two proprietary Aventis compounds formulated in Atrix's delivery technology, Atrigel®. The current agreement is specific for these compounds in an undisclosed therapeutic area.
Human movement is a key factor of dengue virus inflow in Rio de Janeiro, according to results from researchers based at the Oswaldo Cruz Foundation (Fiocruz) in Brazil. The results, based on data from a severe epidemic in 2007-2008, contribute to new understanding on the dynamics of dengue fever in the second largest city in Brazil. Details are published November 10 in the open-access journal PLoS Neglected Tropical Diseases.
DK Sinopharma, Inc., formerly known as Virtual Closet, Inc. today announced that on June 30, 2010, the Company's name change from Virtual Closet, Inc. to DK Sinopharma, Inc. took effect in the marketplace. The OTCBB symbol has also changed from VIRZ to DKSP to reflect the change in name. The name and symbol change became effective through FINRA on June 30, 2010.
› Verified 6 days ago
Albert Poet, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 703 Mill Creek Rd, Suite G, Manahawkin, NJ 08050 Phone: 609-597-6800 Fax: 609-597-5282 | |
Dr. Edward I Engle, DO Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1145 Beacon Avenue, Manahawkin, NJ 08050 Phone: 609-597-7110 Fax: 609-597-7113 | |
Dr. Bruce J Romanczuk, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1145 Beacon Avenue, Manahawkin, NJ 08050 Phone: 609-597-7110 Fax: 609-597-7113 | |
Dr. Orest Bezpalko, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 77 Nautilus Dr, Manahawkin, NJ 08050 Phone: 609-597-0321 Fax: 609-597-0014 |